NO333162B1 - Anvendelse av GE 2270 faktor A3-amidderivat for behandling av akne. - Google Patents

Anvendelse av GE 2270 faktor A3-amidderivat for behandling av akne. Download PDF

Info

Publication number
NO333162B1
NO333162B1 NO20040662A NO20040662A NO333162B1 NO 333162 B1 NO333162 B1 NO 333162B1 NO 20040662 A NO20040662 A NO 20040662A NO 20040662 A NO20040662 A NO 20040662A NO 333162 B1 NO333162 B1 NO 333162B1
Authority
NO
Norway
Prior art keywords
acne
use according
pharmaceutically acceptable
medicament
compound
Prior art date
Application number
NO20040662A
Other languages
English (en)
Norwegian (no)
Other versions
NO20040662L (no
Inventor
Adriano Malabarba
Marco Cavaleri
Giorgio Mosconi
Daniela Jabes
Gabriella Romano
Original Assignee
Naicons Scarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naicons Scarl filed Critical Naicons Scarl
Publication of NO20040662L publication Critical patent/NO20040662L/no
Publication of NO333162B1 publication Critical patent/NO333162B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20040662A 2002-06-17 2004-02-16 Anvendelse av GE 2270 faktor A3-amidderivat for behandling av akne. NO333162B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02013268 2002-06-17
PCT/EP2003/005989 WO2003105881A1 (fr) 2002-06-17 2003-06-06 Utilisation de derives amido du ge 2270 facteur a3 pour le traitement de l'acne

Publications (2)

Publication Number Publication Date
NO20040662L NO20040662L (no) 2004-04-05
NO333162B1 true NO333162B1 (no) 2013-03-25

Family

ID=29724391

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040662A NO333162B1 (no) 2002-06-17 2004-02-16 Anvendelse av GE 2270 faktor A3-amidderivat for behandling av akne.

Country Status (17)

Country Link
US (1) US7655676B2 (fr)
EP (1) EP1553967B1 (fr)
JP (1) JP4723857B2 (fr)
KR (1) KR20050026401A (fr)
AR (1) AR039682A1 (fr)
AT (1) ATE509633T1 (fr)
AU (1) AU2003242647B2 (fr)
BR (1) BR0305070A (fr)
CA (1) CA2489705C (fr)
CY (1) CY1111734T1 (fr)
DK (1) DK1553967T3 (fr)
ES (1) ES2364269T3 (fr)
NO (1) NO333162B1 (fr)
PT (1) PT1553967E (fr)
SI (1) SI1553967T1 (fr)
TW (1) TWI329650B (fr)
WO (1) WO2003105881A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
BRPI0720542A2 (pt) 2006-12-20 2014-01-21 Novartis Ag Compostos antibacterianos e processos para a sua produção
CN101772506B (zh) * 2007-06-04 2014-02-12 诺华股份有限公司 大环化合物及其用途
EP2229386B1 (fr) 2007-12-12 2015-06-03 Novartis AG Un derive d'aminothiazole et son utilisation en tant qu'agent antibacterien
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
FR3004939B1 (fr) * 2013-04-26 2015-05-22 Oreal Huile essentielle de satureja montana a forte teneur en geraniol, et utilisation pour traiter les peaux grasses et/ou les defauts esthetiques associes
DE102013215828A1 (de) * 2013-08-09 2015-02-12 Beiersdorf Ag Gelförmiges Sonnenschutzmittel mit Fettalkoholen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86865A1 (fr) * 1987-05-06 1989-01-19 Oreal Nouveaux retinoates d'ammonium quaternaires,leur utilisation en cosmetique et en dermopharmacie
DE3784738T2 (de) * 1987-06-12 1993-07-08 Molecular Design Int Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
DE69016284T2 (de) 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
JP2693859B2 (ja) 1990-09-28 1997-12-24 高砂香料工業株式会社 尋常性▲ざ▼瘡用皮膚外用剤
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
JP2907640B2 (ja) 1992-06-29 1999-06-21 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
JP2937667B2 (ja) 1992-11-19 1999-08-23 高砂香料工業株式会社 尋常性ざ瘡用皮膚外用剤
DE69600244T2 (de) * 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ES2186866T3 (es) 1996-02-14 2003-05-16 Biosearch Italia Spa Derivados de factores del antibiotico ge2270.
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US6009225A (en) * 1998-05-26 1999-12-28 Ray; Craig D. Fiber optic drop splice closure and related methods

Also Published As

Publication number Publication date
EP1553967B1 (fr) 2011-05-18
WO2003105881A1 (fr) 2003-12-24
JP4723857B2 (ja) 2011-07-13
ATE509633T1 (de) 2011-06-15
CA2489705A1 (fr) 2003-12-24
AU2003242647A1 (en) 2003-12-31
ES2364269T3 (es) 2011-08-30
BR0305070A (pt) 2004-09-21
KR20050026401A (ko) 2005-03-15
CY1111734T1 (el) 2015-10-07
SI1553967T1 (sl) 2011-07-29
HK1074402A1 (en) 2005-11-11
DK1553967T3 (da) 2011-08-29
AU2003242647B2 (en) 2009-10-22
JP2005529947A (ja) 2005-10-06
NO20040662L (no) 2004-04-05
TWI329650B (en) 2010-09-01
AR039682A1 (es) 2005-03-09
PT1553967E (pt) 2011-08-01
CA2489705C (fr) 2012-08-14
TW200402425A (en) 2004-02-16
US7655676B2 (en) 2010-02-02
US20070117825A1 (en) 2007-05-24
EP1553967A1 (fr) 2005-07-20

Similar Documents

Publication Publication Date Title
Jappe Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy
Dreno Topical antibacterial therapy for acne vulgaris
US20070003585A1 (en) Topical skin treating compositions
WO1999059580A1 (fr) Agents preventifs/therapeutiques pour les affections cutanees
CN104114166A (zh) 包含dgla、15-ohepa和/或15-hetre的抗微生物组合物及其使用方法
AU2009244819A1 (en) Proguanil to treat skin/mucosal diseases
US20040171561A1 (en) Topical formulations for treatment of rosacea
CN103347507A (zh) 用于治疗痤疮的褪黑激素以及抗微生物剂或抗菌剂
CN102740846A (zh) 用于局部给药的组合物
NO333162B1 (no) Anvendelse av GE 2270 faktor A3-amidderivat for behandling av akne.
Fleischer Jr Implications for Patient Care
PT1515710E (pt) Método de tratamento de rosácea por aplicação tópica de um derivado de ciclo-hexano
EP1663195B1 (fr) Procede pour inhiber la croissance de bacteries et de champignons pathogenes et composition microbicide
JP2003246726A (ja) 抗菌組成物
CN112236163B (zh) 使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用
WO2017020036A1 (fr) Compositions et méthodes associées de traitement de maladies pilo-sébacées
HK1074402B (en) Use of amide derivative of ge 2270 factor a3 for the treatment of acne
KR20180135169A (ko) 퀘르세틴 및 비타민 d를 함유하는 여드름 피부 개선용 조성물
Ćorić Development and Evaluation of a Clindamycin Hydrochloride Gel Formulation for Topical Application

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees